中文产业新闻精选评分69Chinese source
FDA 批准 Ziihera 联合替雷利珠单抗等方案，HER2 阳性胃食管腺癌获一线联合治疗
中国药企自主研发PD-1再下一城！替雷利珠单抗进入HER2阳性胃癌一线
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
中国药企自主研发PD-1再下一城！替雷利珠单抗进入HER2阳性胃癌一线
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.